A Chinese scientist reviewing laboratory equipment

Research news

This section contains news items that were not issued as a press release.

Thursday, 20 December 2012
AstraZeneca and LegoChem Biosciences announce collaboration on treatment of antibiotic-resistant bacterial infections AstraZeneca has entered into a research and development option & license agreement with LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant bacterial infections.
Tuesday, 18 December 2012
AstraZeneca and Fudan University sign research collaboration in China AstraZeneca today announced the signing of a research collaboration with Fudan University, one of China’s leading academic institutions in the area of cardiovascular diseases (CVDs), a leading cause of death in China and worldwide.
Tuesday, 11 December 2012
AstraZeneca and Isis Pharmaceuticals form strategic alliance on RNA therapeutics for cancer AstraZeneca and Isis Pharmaceuticals, Inc.  today announced a strategic alliance for the discovery and development of novel generation antisense therapeutics against five cancer targets.
Tuesday, 11 December 2012
New Tuberculosis drug trial begins in South Africa Case Western Reserve University and AstraZeneca partner to test novel therapy
Tuesday, 4 December 2012
AstraZeneca to collaborate with the Health and Social Care Information Centre in health data initiative AstraZeneca today announced it has signed a memorandum of understanding with the Health and Social Care Information Centre (HSCIC) to improve the usefulness of real-world data in healthcare decision making and better understand the role medicines play in helping patients with chronic diseases in England.
Thursday, 29 November 2012
AstraZeneca wins Scrip Award for “Best Partnership Alliance” for third consecutive year AstraZeneca’s industry-leading alliance with the UK Medical Research Council (MRC) won the “Best Partnership Alliance” award at the annual Scrip Awards event in London, marking the third consecutive year that AstraZeneca has captured this prestigious award.
Friday, 23 November 2012
Creation of the NĒOMED Institute: renewing biopharmaceutical AstraZeneca Canada and Pfizer Canada join forces with the Government of Québec to establish a new R&D model in the biopharmaceutical industry.
Wednesday, 14 November 2012
AstraZeneca appoints Dr. Shridhar Narayanan to lead infection research in Bangalore BANGALORE, INDIA –AstraZeneca today announced it has appointed Dr. Shridhar Narayanan to the position of Vice President and Head, Infection iScience, Bangalore, effective November 2012.
Monday, 12 November 2012
Foundation Medicine and AstraZeneca announce genomic profiling collaboration Collaboration seeks to enhance clinical trial design by identifying genomic predictors of response to targeted cancer therapies
Friday, 2 November 2012
Experimental Combination Therapy trial for Breast Cancer patients no longer responding to therapy CANCER RESEARCH UK’s Drug Development Office (DDO) has joined forces with academia and industry to trial an experimental drug from AstraZeneca called AZD4547 in combination with existing therapies, to treat post-menopausal women whose breast cancer has spread and is no longer responding to standard treatment.